Study Director 3 - Toxicology
No salary listed
Expert
Bachelor's, Master's, PhD
Mt Vernon, IN, USA
In Person
Biology & BiotechClinical Research Operations
About the job
Requirements
- Ability to read, write, speak, and understand English.
- Ability to read, write, and understand oral and/or written instructions.
- Ability to read, write, and interpret scientific material.
- Manual dexterity to perform research functions, type, and use office equipment.
- Ability to stand or sit for long periods of time.
- Frequent involvement with radiant/electrical energy, solvents, grease, oil, irritants, acids, bases, other hazardous chemicals, electro-mechanical hazards, flammable materials, and biohazards; immunization against diseases may be required due to exposure to hazardous biological materials, which may include HIV-positive specimens.
- Ability to work with animal dander, bites, scratches, and materials associated with animal husbandry.
- Ability to wear latex gloves, dust mask and/or respirator, and safety glasses as required.
- Ability to work in moderate-to-loud noise requiring ear protection.
- Negative Mantoux TB test required.
- Bachelor’s degree and 10 years of relevant experience, or master’s degree and 5 years of relevant experience, or doctoral degree in one of the biological sciences and at least 2 years of relevant laboratory animal experience.
- Good organizational skills.
- Ability to use a computer to compile and maintain databases for records and inventory using appropriate software.
- Knowledge and understanding of cGMP/GLP/GCP and OECD regulations, as applicable, and ability to apply these practices daily.
- Ability to work independently.
- Good written and oral communication skills.
- Ability to adhere to all safety regulations and procedures.
- Ability to document analytical results.
Responsibilities
- Responsible for all phases of protocol development, communicating with supervisory staff to establish a study schedule, the sponsor to finalize the protocol, and technical staff to coordinate study initiation.
- Direct and/or supervise the work of technical staff in accordance with GLP requirements.
- Monitor study progress and, after consultation with senior staff, report results to the sponsor.
- Participate in in-house training programs for technical staff.
- Conduct literature and/or internet searches in support of protocol or report preparation.
- With assistance from senior staff, prepare posters and/or scientific papers contributing to the scientific reputation of Inotiv Evansville and the individual.
- In consultation with senior staff, prepare reports, papers, and/or charts of study data for interim reports to the sponsor.
- Maintain knowledge of FDA and other regulatory guidelines that may affect protocol development.
- Inform management of issues affecting the conduct of preclinical studies, interaction with clients, and/or generation of protocols and reports.
- Perform other duties as assigned.
- Maintain confidential information.
- Interact with the community and employees.
- Support and participate in other company initiatives as directed by management.
About the company
Inotiv provides contract research services across drug discovery, preclinical testing, analytical testing, and related areas for the pharmaceutical and biotech industries. Its offerings combine analytical chemistry, preclinical research, and access to a broad set of research models to generate data and prepare regulatory-compliant documentation that supports drug development, safety testing, and medical device evaluation. The company differentiates itself through an integrated CRO model that pairs BASi’s analytical capabilities, Seventh Wave’s preclinical work, and Envigo’s research models in one end-to-end service. Its goal is to be a global partner for drug discovery, safety assessment, and product development by delivering scalable research services and regulatory-grade data to biopharma and medical device customers.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
West Lafayette, Indiana
Founded
1974
Get referred to Inotiv
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 20, 2026 restructuring improved liquidity and strengthened Inotiv's balance sheet.
- Q1 fiscal 2026 backlog reached $145.4 million, supporting near-term DSA revenue visibility.
- Management kept normal operations through bankruptcy, preserving clients, vendors, and service continuity.
What critics are saying
- June 2026 Chapter 11 cancelled existing equity, wiping out prior shareholders.
- USDA cited Inotiv facilities in April 2026 and August 2026 for critical violations.
- Animal-welfare scandals and bankruptcy stigma threaten customer trust and future contract wins.
What makes Inotiv unique
- Inotiv pairs preclinical CRO services with research models and analytical capabilities.
- July 2026 emergence from Chapter 11 cut about $326 million of debt.
- Its VUGENE collaboration adds AI bioinformatics across Discovery and Translational Sciences.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Pension
- Life Insurance
- Wellbeing Program
- Paid Time Off
- 401(k) Retirement Plan
- Flexible Work Hours
- Remote Work Options
- Stock Options
- Company Equity
- Conference Attendance Budget
- Professional Development Budget